Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Utah Medical Products Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of UTMD: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders82187+6
Shares2.55M94.0K2.54M+90.6K (+3.7%)
Value$256.0M$9.45M$241.0M−$5.52M (−2.2%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Utah Medical Products Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to UTMD in Q1 2023
InstitutionSharesValue% of portfolio
Brandes Investment Partners, LP21,505$2.04M0.04%
Millennium Management LLC8,151$772.0K0.00%
Morgan Dempsey Capital Management LLC5,893$558.5K0.15%
Quadrature Capital Ltd4,048$383.6K0.01%
Two Sigma Investments, LP3,952$374.5K0.00%
SG Americas Securities, LLC1,402$133.0K0.00%
WR Wealth Planners, LLC66$6.25K0.00%
Global Retirement Partners, LLC20$1.86K0.00%

Sold out (2)

Institutions that held Utah Medical Products Inc at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of UTMD in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Panagora Asset Management Inc2,737$275.2K
Rockefeller Capital Management L.P.131$13.0K

Not filed for Q1 2023 yet (1)

Institutions that held Utah Medical Products Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding UTMD in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
HealthInvest Partners AB94,000$9.45M